Skip to main content
Top
Published in: Journal of the International Society of Sports Nutrition 1/2009

Open Access 01-12-2009 | Research article

Examination of a pre-exercise, high energy supplement on exercise performance

Authors: Jay R Hoffman, Jie Kang, Nicholas A Ratamess, Mattan W Hoffman, Christopher P Tranchina, Avery D Faigenbaum

Published in: Journal of the International Society of Sports Nutrition | Issue 1/2009

Login to get access

Abstract

Background

The purpose of this study was to examine the effect of a pre-exercise high energy drink on reaction time and anaerobic power in competitive strength/power athletes. In addition, the effect of the pre-exercise drink on subjective feelings of energy, fatigue, alertness and focus was also explored.

Methods

Twelve male strength/power athletes (21.1 ± 1.3 y; 179.8 ± 7.1 cm; 88.6 ± 12.1 kg; 17.6 ± 3.3% body fat) underwent two testing sessions administered in a randomized and double-blind fashion. During each session, subjects reported to the Human Performance Laboratory and were provided with either 120 ml of a high energy drink (SUP), commercially marketed as Redline Extreme® or 120 ml of a placebo (PL) that was similar in taste and appearance but contained no active ingredients. Following consumption of the supplement or placebo subjects rested quietly for 10-minutes prior to completing a survey and commencing exercise. The survey consisted of 4 questions asking each subject to describe their feelings of energy, fatigue, alertness and focus for that moment. Following the completion of the questionnaire subjects performed a 2-minute quickness and reaction test on the Makoto testing device (Makoto USA, Centennial CO) and a 20-second Wingate Anaerobic Power test. Following a 10-minute rest subjects repeated the testing sequence and after a similar rest period a third and final testing sequence was performed. The Makoto testing device consisted of subjects reacting to both a visual and auditory stimulus and striking one out of 30 potential targets on three towers.

Results

Significant difference in reaction performance was seen between SUP and PL in both average number of targets struck (55.8 ± 7.4 versus 51.9 ± 7.4, respectively) and percent of targets struck (71.9 ± 10.5% versus 66.8 ± 10.9%, respectively). No significant differences between trials were seen in any anaerobic power measure. Subjective feelings of energy (3.5 ± 0.5 versus 3.1 ± 0.5) and focus (3.8 ± 0.5 versus 3.3 ± 0.7) were significantly higher during SUP compared to PL, respectively. In addition, a trend towards an increase in average alertness (p = 0.06) was seen in SUP compared to P.

Conclusion

Results indicate a significant increase in reaction performance, with no effect on anaerobic power performance. In addition, ingestion of this supplement significantly improves subjective feelings of focus and energy in male strength/power athletes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hoffman JR, Faigenbaum AD, Ratamess NA, Ross R, Kang J, Tenenbaum G: Nutritional Supplementation and Anabolic Steroid Use in Adolescents. Med Sci Sports Exerc. 2008, 40: 15-24.CrossRefPubMed Hoffman JR, Faigenbaum AD, Ratamess NA, Ross R, Kang J, Tenenbaum G: Nutritional Supplementation and Anabolic Steroid Use in Adolescents. Med Sci Sports Exerc. 2008, 40: 15-24.CrossRefPubMed
2.
go back to reference Froiland K, Koszewski W, Hingst J, Kopecky L: Nutritional supplement use among college athletes and their sources of information. Int J Sport Nutr Exerc Metab. 2004, 14 (1): 104-120.PubMed Froiland K, Koszewski W, Hingst J, Kopecky L: Nutritional supplement use among college athletes and their sources of information. Int J Sport Nutr Exerc Metab. 2004, 14 (1): 104-120.PubMed
3.
go back to reference Bell A, Dorsch KD, McCreary DR, Hovey R: A look at nutritional supplement use in adolescents. J Adolesc Health. 2004, 34: 508-516.CrossRefPubMed Bell A, Dorsch KD, McCreary DR, Hovey R: A look at nutritional supplement use in adolescents. J Adolesc Health. 2004, 34: 508-516.CrossRefPubMed
4.
go back to reference Dodge TL, Jaccard JJ: The effect of high school sports participation on the use of performance-enhancing substances in young adulthood. J Adolesc Health. 2006, 39: 367-373. 10.1016/j.jadohealth.2005.12.025.CrossRefPubMed Dodge TL, Jaccard JJ: The effect of high school sports participation on the use of performance-enhancing substances in young adulthood. J Adolesc Health. 2006, 39: 367-373. 10.1016/j.jadohealth.2005.12.025.CrossRefPubMed
5.
go back to reference Hoffman JR, Kang J, Ratamess NA, Jennings PF, Mangine G, Faigenbaum AD: Effect of Nutritionally Enriched Coffee Consumption on Aerobic and Anaerobic Exercise Performance. J Strength Cond Res. 2007, 21: 456-459. 10.1519/R-20326.1.PubMed Hoffman JR, Kang J, Ratamess NA, Jennings PF, Mangine G, Faigenbaum AD: Effect of Nutritionally Enriched Coffee Consumption on Aerobic and Anaerobic Exercise Performance. J Strength Cond Res. 2007, 21: 456-459. 10.1519/R-20326.1.PubMed
6.
go back to reference Ratamess NA, Hoffman JR, Ross R, Shanklin M, Faigenbaum AD, Kang : Effects of an Amino Acid/Creatine/Energy Supplement on Performance and the Acute Hormonal Response to Resistance Exercise. Int J Sport Nutr Exerc Metab. 2007, 17: 608-623.PubMed Ratamess NA, Hoffman JR, Ross R, Shanklin M, Faigenbaum AD, Kang : Effects of an Amino Acid/Creatine/Energy Supplement on Performance and the Acute Hormonal Response to Resistance Exercise. Int J Sport Nutr Exerc Metab. 2007, 17: 608-623.PubMed
7.
go back to reference Hoffman JR, Ratamess NA, Ross R, Shanklin M, Kang J, Faigenbaum AD: Effect of a Pre-Exercise 'High-Energy' Supplement Drink on the Acute Hormonal Response to Resistance Exercise. J Strength Cond Res. 2008, 22: 874-882.CrossRefPubMed Hoffman JR, Ratamess NA, Ross R, Shanklin M, Kang J, Faigenbaum AD: Effect of a Pre-Exercise 'High-Energy' Supplement Drink on the Acute Hormonal Response to Resistance Exercise. J Strength Cond Res. 2008, 22: 874-882.CrossRefPubMed
8.
9.
go back to reference Doherty M, Smith PM: Effects of caffeine ingestion on exercise testing: A meta-analysis. Int J Sports Nutr Exerc Metab. 2004, 14: 626-646. Doherty M, Smith PM: Effects of caffeine ingestion on exercise testing: A meta-analysis. Int J Sports Nutr Exerc Metab. 2004, 14: 626-646.
10.
go back to reference Graham TE, Hibbert E, Sathasivam P: Metabolic and exercise endurance effects of coffee and caffeine ingestion. J Appl Physiol. 1998, 85: 883-889.PubMed Graham TE, Hibbert E, Sathasivam P: Metabolic and exercise endurance effects of coffee and caffeine ingestion. J Appl Physiol. 1998, 85: 883-889.PubMed
11.
go back to reference Graham TE, Spriet LL: Performance and metabolic responses to a high caffeine dose during prolonged exercise. J Appl Physiol. 1995, 78: 867-874.PubMed Graham TE, Spriet LL: Performance and metabolic responses to a high caffeine dose during prolonged exercise. J Appl Physiol. 1995, 78: 867-874.PubMed
12.
go back to reference Spriet LL: Caffeine and performance. Int J Sport Nutr. 1995, 5: S84-S99.PubMed Spriet LL: Caffeine and performance. Int J Sport Nutr. 1995, 5: S84-S99.PubMed
13.
go back to reference Kalmar JM: The influence of caffeine on voluntary muscle activation. Med Sci Sports Exerc. 2005, 37: 2113-2119. 10.1249/01.mss.0000178219.18086.9e.CrossRefPubMed Kalmar JM: The influence of caffeine on voluntary muscle activation. Med Sci Sports Exerc. 2005, 37: 2113-2119. 10.1249/01.mss.0000178219.18086.9e.CrossRefPubMed
14.
go back to reference Bell DG, Jacobs I, Ellerington K: Effect of caffeine and ephedrine ingestion on anaerobic exercise performance. Med Sci Sports Exerc. 2001, 33: 1399-1403. 10.1097/00005768-200105001-01690.CrossRefPubMed Bell DG, Jacobs I, Ellerington K: Effect of caffeine and ephedrine ingestion on anaerobic exercise performance. Med Sci Sports Exerc. 2001, 33: 1399-1403. 10.1097/00005768-200105001-01690.CrossRefPubMed
15.
go back to reference Hoffman JR, Stout JR: Performance-Enhancing Substances. Essentials of Strength and Conditioning. Edited by: Earle RW, Baechle TR. 2008, Human Kinetics: Champaign, IL, 179-200. 3 Hoffman JR, Stout JR: Performance-Enhancing Substances. Essentials of Strength and Conditioning. Edited by: Earle RW, Baechle TR. 2008, Human Kinetics: Champaign, IL, 179-200. 3
16.
go back to reference Shekelle P, Hardy M, Morton S, Maglione M, Suttorp M, Roth E, Jungvig L: Ephedra and Ephedrine for Weight Loss and Athletic Performance Enhancement: Clinical Efficacy and Side Effects. Evidence Report/Technology Assessment No. 76 (Prepared by Southern California Evidence-based Practice Center, RAND, under Contract No290-97-0001, Task Order No. 9). AHRQ Publication No. 03-E022. 2003, Rockville, MD: Agency for Healthcare Research and Quality Shekelle P, Hardy M, Morton S, Maglione M, Suttorp M, Roth E, Jungvig L: Ephedra and Ephedrine for Weight Loss and Athletic Performance Enhancement: Clinical Efficacy and Side Effects. Evidence Report/Technology Assessment No. 76 (Prepared by Southern California Evidence-based Practice Center, RAND, under Contract No290-97-0001, Task Order No. 9). AHRQ Publication No. 03-E022. 2003, Rockville, MD: Agency for Healthcare Research and Quality
17.
go back to reference Galitzky J, Taouis M, Berlan M, Riviere D, Garrigues M, Lafontan M: Alpha 2-antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers. Eur J Clin Invest. 1988, 18: 587-594. 10.1111/j.1365-2362.1988.tb01272.x.CrossRefPubMed Galitzky J, Taouis M, Berlan M, Riviere D, Garrigues M, Lafontan M: Alpha 2-antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers. Eur J Clin Invest. 1988, 18: 587-594. 10.1111/j.1365-2362.1988.tb01272.x.CrossRefPubMed
18.
go back to reference Lafontan M, Berlan M, Galitzky J, Montastruc JL: Alpha-2 adrenoceptors in lipolysis: alpha 2 antagonists and lipid-mobilizing strategies. Am J Clin Nutr. 1992, 55 (1 Suppl): 219S-227S.PubMed Lafontan M, Berlan M, Galitzky J, Montastruc JL: Alpha-2 adrenoceptors in lipolysis: alpha 2 antagonists and lipid-mobilizing strategies. Am J Clin Nutr. 1992, 55 (1 Suppl): 219S-227S.PubMed
19.
go back to reference Kobayashi Y, Nakano Y, Kizaki M, Hoshikuma K, Yokoo Y, Komiya T: Capsaicin-like anti-obese activities of evodiamine from fruits of Evodia rutaecarpa, a vanilloid receptor agonist. Planta Med. 2001, 67: 628-633. 10.1055/s-2001-17353.CrossRefPubMed Kobayashi Y, Nakano Y, Kizaki M, Hoshikuma K, Yokoo Y, Komiya T: Capsaicin-like anti-obese activities of evodiamine from fruits of Evodia rutaecarpa, a vanilloid receptor agonist. Planta Med. 2001, 67: 628-633. 10.1055/s-2001-17353.CrossRefPubMed
20.
go back to reference Kobayashi Y: The nociceptive and anti-nociceptive effects of evodiamine from fruits of Evodia rutaecarpa in mice. Planta Med. 2003, 69: 425-428. 10.1055/s-2003-39701.CrossRefPubMed Kobayashi Y: The nociceptive and anti-nociceptive effects of evodiamine from fruits of Evodia rutaecarpa in mice. Planta Med. 2003, 69: 425-428. 10.1055/s-2003-39701.CrossRefPubMed
21.
go back to reference Slezak T, Francis PS, Anastos N, Barnett NW: Determination of synephrine in weight-loss products using high performance liquid chromatography with acidic potassium permanganate chemiluminescence detection. Analy Chem Acta. 2007, 593: 98-102. 10.1016/j.aca.2007.04.038.CrossRef Slezak T, Francis PS, Anastos N, Barnett NW: Determination of synephrine in weight-loss products using high performance liquid chromatography with acidic potassium permanganate chemiluminescence detection. Analy Chem Acta. 2007, 593: 98-102. 10.1016/j.aca.2007.04.038.CrossRef
22.
go back to reference Fugh-Berman A, Myers A: Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: Current status of clinical and basic research. Exp Biol Med (Maywood). 2004, 229 (8): 698-704. Fugh-Berman A, Myers A: Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: Current status of clinical and basic research. Exp Biol Med (Maywood). 2004, 229 (8): 698-704.
23.
go back to reference Youdim MB, Weinstock M: Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation. Neurotoxicology. 2004, 25: 243-250. 10.1016/S0161-813X(03)00103-7.CrossRefPubMed Youdim MB, Weinstock M: Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation. Neurotoxicology. 2004, 25: 243-250. 10.1016/S0161-813X(03)00103-7.CrossRefPubMed
24.
go back to reference Fenstrom JD: Branced-chain amino acids and brain function. J Nutr. 2005, 135: 1539S-1546S. Fenstrom JD: Branced-chain amino acids and brain function. J Nutr. 2005, 135: 1539S-1546S.
25.
go back to reference Shah SN: Adjuvant role of vitamin B analogue (sulbutiamine) with anti-infective treatment in infection associated asthenia. J Assoc Physicians India. 2003, 51: 891-895.PubMed Shah SN: Adjuvant role of vitamin B analogue (sulbutiamine) with anti-infective treatment in infection associated asthenia. J Assoc Physicians India. 2003, 51: 891-895.PubMed
26.
go back to reference Tiev KP, Cabane J, Imbert JC: Treatment of chronic postinfectious fatigue: randomized double-blind study of two doses of sulbutiamine (400–600 mg/day) versus placebo. Rev Med Interne. 1999, 20: 912-918.CrossRefPubMed Tiev KP, Cabane J, Imbert JC: Treatment of chronic postinfectious fatigue: randomized double-blind study of two doses of sulbutiamine (400–600 mg/day) versus placebo. Rev Med Interne. 1999, 20: 912-918.CrossRefPubMed
27.
go back to reference Kidd PM: A review of nutrients and botanicals in the integrative management of cognitive dysfunction. Altern Med Rev. 1999, 4: 144-161.PubMed Kidd PM: A review of nutrients and botanicals in the integrative management of cognitive dysfunction. Altern Med Rev. 1999, 4: 144-161.PubMed
28.
go back to reference Dunnett M, Harris RC: Influence of oral beta-alanine and L-histidine supplementation on the carnosine content of the gluteus medius. Equine Vet J Suppl. 1999, 30: 499-504.PubMed Dunnett M, Harris RC: Influence of oral beta-alanine and L-histidine supplementation on the carnosine content of the gluteus medius. Equine Vet J Suppl. 1999, 30: 499-504.PubMed
29.
go back to reference Nakamura M, Ishii A, Nakahara D: Characterization of β-phenylethylamine-induced monamine release in rat nucleus accumbens: a microdialysis study. Eur J Pharmacol. 1998, 349: 163-169. 10.1016/S0014-2999(98)00191-5.CrossRefPubMed Nakamura M, Ishii A, Nakahara D: Characterization of β-phenylethylamine-induced monamine release in rat nucleus accumbens: a microdialysis study. Eur J Pharmacol. 1998, 349: 163-169. 10.1016/S0014-2999(98)00191-5.CrossRefPubMed
30.
go back to reference Rahman MK, Nagatsu T, Sakurai T, Hori S, Abe M, Matsuda M: Effect of pyridoxal phosphate deficiency on aromatic L-amino acid decarboxylase activity with L-DOPA and L-5-hydroxytryptophan as substrates in rats. Jpn J Pharmacol. 1982, 32: 803-811. 10.1254/jjp.32.803.CrossRefPubMed Rahman MK, Nagatsu T, Sakurai T, Hori S, Abe M, Matsuda M: Effect of pyridoxal phosphate deficiency on aromatic L-amino acid decarboxylase activity with L-DOPA and L-5-hydroxytryptophan as substrates in rats. Jpn J Pharmacol. 1982, 32: 803-811. 10.1254/jjp.32.803.CrossRefPubMed
31.
go back to reference Simbrey K, Winterhoff H, Butterweck V: Extracts of St. John's wort and various constituents affect beta-adrenergic binding in rat frontal cortex. Life Sci. 2003, 74: 1027-1038. 10.1016/j.lfs.2003.07.027.CrossRef Simbrey K, Winterhoff H, Butterweck V: Extracts of St. John's wort and various constituents affect beta-adrenergic binding in rat frontal cortex. Life Sci. 2003, 74: 1027-1038. 10.1016/j.lfs.2003.07.027.CrossRef
Metadata
Title
Examination of a pre-exercise, high energy supplement on exercise performance
Authors
Jay R Hoffman
Jie Kang
Nicholas A Ratamess
Mattan W Hoffman
Christopher P Tranchina
Avery D Faigenbaum
Publication date
01-12-2009
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1550-2783-6-2

Other articles of this Issue 1/2009

Journal of the International Society of Sports Nutrition 1/2009 Go to the issue